Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
Search
 
My Lists

Nora Therapeutics

530 Lytton Avenue, 2nd floor
Palo Alto, CA 94301
USA
Website Company Summary Management Team
Management

General Management: Chris B McClain (2004)
Technology: Darryl L Carter ; Vera Wolowodiuk (6/30/2012)
Former Employees: Jeffrey K Tong Mark Joing Paul K Kwon
Board

Outside board: (May no longer be on the board) Heath Lukatch (Novo A/S Managing Director)
Company

Business description: Nora Therapeutics is a specialty biopharmaceutical company focused on developing therapeutics to address clinical unmet needs in reproductive medicine. Nora’s lead compound, NT100, is a novel treatment being studied to improve pregnancy success rates and outcomes for women who have undergone multiple unsuccessful in vitro fertilization (IVF) procedures. NT100 is a novel biologic agent similar to a naturally occurring protein in the female reproductive tract. NT100’s mechanism of action may better enable embryo implantation and pregnancy maintenance by optimizing maternal-fetal immune tolerance.
Capital

Rounds: 2
Recent Fundings: Apr 2014   Jun 2010
Capital raised: 20.9M
Last Round: 18.0M
Ownership: Private  

Last Tweets


 

Last Mentions


Overview
Record updated: Apr 2014
Sector: Medical
Headcount: 11-25
Rounds: 2
Recent Fundings: Apr 2014   Jun 2010
Capital Raised: 20.9M
Last Round: 18.0M
Ownership: Private